Unknown PHASE4 INTERVENTIONAL 1-arm NCT02539069

The Post-marketing Surveillance to Evaluate the Efficacy of CHONDRON (Autologous Cultured Chondrocyte) by Arthroscopy

A Post-marketing Surveillance to Evaluate the Efficacy and Safety of CHONDRON (Autologous Cultured Chondrocyte) Through Arthroscopy in Patients With Knee Cartilage Defects

Sponsor: Sewon Cellontech Co., Ltd.

Conditions Osteoarthritis Traumatic Arthritis

Interventions Chondron Implantation

Updated 7 times since 2017 Last updated: Sep 1, 2015 Started: Aug 31, 2012 Primary completion: Feb 28, 2015 Completion: Aug 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Osteoarthritis and Traumatic Arthritis, this trial is ongoing. The trial is conducted by Sewon Cellontech Co., Ltd. and has accumulated 7 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE4
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4

▶ Show 2 earlier versions

Sep 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

Status: Active Not Recruiting → Unknown Status
Jan 2017 — Sep 2017 [monthly]

Active Not Recruiting PHASE4

First recorded

Aug 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Sewon Cellontech Co., Ltd.

Data source: Sewon Cellontech Co., Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seoul, South Korea